Symrise AG held its Annual General Meeting in the Townhall Holzminden on May 6, 2026. The Supervisory Board and Executive Board welcomed around 350 shareholders. First, CEO Dr Jean-Yves Parisot reported on the 2025 financial year, which yielded solid growth and the highest profitability in ten years. Within the ONE Symrise strategy, the company has steadily developed its portfolio and continued to advance its transformation program with a focus on investing in growth. The innovative Care & Wellness division as a key value driver plays an essential role in this journey. Thereafter, the shareholders approved all proposed resolutions. These included an increase in the dividend to €1.25 per share and the welcome of three new Supervisory Board members.

"I would like to thank our shareholders for the open exchange and their trust in the course we have chosen," said Dr Jean-Yves Parisot, CEO of Symrise. "In 2025, we achieved solid organic growth in view of challenging conditions. At the same time, we realized the highest profitability in ten years. We are consistently developing our company and aligning our portfolio specifically in attractive growth markets, as with our pioneering Care & Wellness division. Simultaneously, we are driving efficiency and are continuing to invest in innovation and capacity to provide new impulses for sustainable growth. With our clear strategic orientation and the targeted ONE SYM transformation, we are creating the basis to strengthen our competitiveness and further expand our market position and create long-term value, that should also benefit our shareholders."

Specifically, Symrise continued the successful course of previous years and achieved solid organic sales growth of 2.8% with consolidated sales of € 4,929 million in the fiscal year 2025. Concurrently, the company significantly increased its profitability and achieved an adjusted EBITDA margin of 21.9%, the highest level in the last decade. To advance its future-oriented path, Symrise has created the Care & Wellness division in the Scent & Care segment. It sets new standards in the industry by combining expertise in cosmetic ingredients, health-related active ingredients and biotics addressing the growing demand for integrated solutions in health, well-being and beauty. This allows Symrise to focus on key consumer trends early on and to translate them into concrete solutions for evolving customer wishes.

In the general debate, the shareholders discussed with the Executive Board and the Supervisory Board the business development and strategic prospects of Symrise. Thereafter, the shareholders followed the proposals of the Executive Board and the Supervisory Board for all items on the agenda put to vote. This also included a dividend increase to €1.25 per share. The payment will be made on May 11, 2026.

The assembly also approved personnel changes in the Supervisory Board: It elected Eva Kienle as a new member to the Supervisory Board, who will further strengthen the competence of the panel with her international financial expertise. On the employee side, two new representatives to the Supervisory Board will join as well – Claus-Oliver Schmidt and Jens Wellmann. They had been elected in early March 2026, further ensuring a balanced and equal committee structure. In this context, the Chairman of the Supervisory Board thanked the leaving Supervisory Board members Bernd Hirsch, Harald Feist and Jacob Ley for their many years of commitment and valuable contribution. The new Executive Board member for the Scent & Care segment, Michael Friede, also attended the Annual General Meeting. In this role, he aims at creating and increasing customer value.

“Another big thank you goes to our internal teams that have worked tirelessly to organize and conduct this Annual General Meeting”, closes Dr Jean-Yves Parisot. “We look forward to welcoming our shareholders again next year on May 12, 2027, to the Townhall of Holzminden.

Overview of the resolutions of the Symrise Annual General Meeting 2026

The following items on the agenda were put to the vote:

• Appropriation of the retained profit for the 2025 financial year
• Approval of the actions of the members of the Executive Board for the 2025 financial year
• Approval of the actions of the members of the Supervisory Board for the 2025 financial year
• Appointment of the auditor, the auditor of the consolidated financial statements and other auditors for the 2026 financial year
• Approval of the remuneration report for the financial year 2025
• Approval of the remuneration system for the members of the Executive Board
• Election to the Supervisory Board

The company has published the voting results on its website: https://www.symrise.com/investors/annual-general-meeting/